MedTrace Logo

Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer

NCT02257775 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2018-01-30

No results posted yet for this study

Summary

The objective of this study is to apply Whole-body DW imaging alongside the routine management of patients requiring systemic therapy for metastatic breast cancer to compare the time to progression of individual liver metastases within and between patients following stable disease or partial response to palliative systemic therapy for breast cancer.

Conditions

Interventions

GENETIC

n/a - observational

Sponsors & Collaborators

  • Institute of Cancer Research, United Kingdom

    lead OTHER

Principal Investigators

  • Jill Noble · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-11
Primary Completion
2017-11-23
Completion
2017-11-23

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02257775 on ClinicalTrials.gov